tizanidine · Capsule

What changed in the last 90 days

Every detected change for tizanidine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Central alpha-2 Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• dexmedetomidine hcl· in shortage
• dexmedetomidine hydrochloride in 0.9% sodium chloride· in shortage
• dexmedetomidine· in shortage
• dexmedetomidine hydrochloride· in shortage
• clonidine hci· 1 maker
• clonidine hydrochloride oral· 1 maker
• dexmedetomidine hydrochloride in sodium chloride· 1 maker
• tizandine· 1 maker
• clonidine transdermal system· 2 makers
• guanfacine er· 2 makers
• tizanidine hcl· 2 makers
• gaunfacine· 3 makers

Common questions

Is Tizanidine in shortage right now?

No. FDA does not currently list Tizanidine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Tizanidine?

37 companies have marketed Tizanidine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Tizanidine cost?

The typical pharmacy pays about $0.0319 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.